The effect was studied of the fungal cyclodepsipeptide antibiotics beauvericin and seven distinct enniatins on acyl-CoA: cholesterol acyltransferase (ACAT) activity. In an enzymeassay using rat liver microsomes, all the compounds were found to inhibit ACATactivity. The drug concentration that caused 50%inhibition (IC50 value) of the enzyme activity was determined to be 3.0/jm for beauvericin, indicating that the compoundis one of the most potent ACATinhibitors of microbial origin. Enniatins exhibited much higher IC50 values of 22 to 1 10/xm. More hydrophobic enniatins showed more potent inhibitory activity. Furthermore, the ACATinhibitory activity was evaluated as inhibition of cholesteryl ester formation in a cell assay using J774 macrophages. Calculation of the ratio, CD50 value (the drug concentration causing 50% cell damage)/IC50 value of cholesteryl ester formation, indicated that beauvericin shows the highest specificity. These data indicate that beauvericin is one of the most potent and specific ACATinhibitors of microbial origin.
Acyl-CoA: cholesterol acyltransferase (ACAT) [EC 2.3. 1.26] , which catalyzes the conversion of cellular cholesterol and long chain fatty acyl-CoA to cholesteryl ester, plays an important role in cholesteryl ester accumulation in atherogenesis1} and in cholesterol absorption from intestines2). Since elevated levels of plasma cholesterol is a well-documented risk factor of atherosclerosis, much attention has been paid to ACATinhibitors for the treatment and prevention of atherosclerosis and hypercholesterolemia.
A lot of synthetic ACATinhibitors have been reported having a urea or an amide moiety. Wehave started to find new ACATinhibitors and new lead compounds of microbial origin. During our screening program, fungal strains Fusarium spp. FO-740 and FO-1305 were found to produce ACATinhibitors. The active compounds were identified as beauvericin ( Fig. 1 ) from the former strain and seven components of enniatins (A, Al, B, Bl, D, E and F, Fig. 1 ) from the latter strain3). All of these cyclodepsipeptides were classified as ionophore antibiotics, most of which were originally reported as antifungal or insecticidal antibiotics produced by Beauveria4' 5\ Paecilomyces6\ Fusarium1 ' 8) and Polyporus^spp. However, it is not clearly understood whether these biological activities are due to the ionophoric activity.
The cyclodepsipeptides were found by the authors to show a new biological activity of ACAT inhibition3*.
In this study, we have examined the effect of beauvericin and enniatins on cholesterol Present address: Pfizer Central Research, Nagoya, Pfizer Pharmaceuticals Inc., 5-2 Taketoyo, Aichi 470-23, Japan. Enniatin A  III  III  III  Enniatin Al  I  III  III  Enniatin  B  i  l  l  Enniatin Bl  I  I  III  Enniatin  D  I  I  n  Enniatin  E  I  II (III)  III (II)  Enniatin  F  II  III  III   Beauvericin  IV  IV  IV Enniatin E is a mixture of enniatins El and E23). esterification in isolated rat liver microsomes and cultured cells such as J774 and mouse peritoneal macrophages. These cells are postulated to provide a model of foam cell formation since they have been reported to accumulate large quantities of cholesteryl ester when exposed to normal, abnormal modified lipoproteins and cholesterol-rich phospholipid liposomes9~1 2). Thus, the macorphages were used to evaluate ACATinhibitors. The relationships are discussed between the ACATinhibitory activity, the antimicrobial activity and the hydrophobicity of the ionophore antibiotics.
Materials and Methods

Materials
[l-14C]Oleoly-CoA was purchased from New England Nuclear. Oleoyl-CoA, cholesterol, phosphatidylcholine from soybean and bovine serum albumin (BSA; fatty acid-free from fraction V) were obtained from Sigma. Triton WR-1339 was purchased from Nakarai Chemicals, Ltd. Beauvericin was purified from a cultured broth ofFusarium sp. FO-740. Enniatins A, Al, B, Bl, D, E and F were also purified from Fusarium sp. FO-1305. Synthetic ACATinhibitors (CL 277,08213) and CL 283,54614)) were generous gifts ofPfizer Inc., U.S.A. All other reagents and solvents used were commercial products of analytical grade.
ACATAssay Using Rat Liver Microsomes
Male Wister-Imamichi rats fed a normal diet for 1 week were killed by decapitation and livers were removed. The microsomal fractions of rat livers were prepared as described previously15) and stored at -80°C.
ACATactivity was measured according to the method of Lichtenstein and Brecher15) with some modification. The reaction mixture contained 0. 1 m sodium phosphate (pH 7.4), 100~200 /xg microsomal protein, 300 jum BSA, 30 /m [l-14C]oleoyl-CoA (0.02 /xCi) and a dispersion of cholesterol in Triton WR-1339 (the amounts of cholesterol and Triton WR-1339were 20/ig and 600/ig, respectively) in a total volume of0.2 ml. The cholesterol dispersion was prepared by the method ofBillheimer et al.16). The assay medium was preincubated for 30 minutes at 37°C and the reaction was initiated by the addition of[l-14C]oleoyl-CoA. After a 30-minute incubation the reaction was stopped by an addition of 1.2ml of chloroform -methanol (1 :2) and lipid extracts were prepared according to the method of Folch et al.17) . The cholesteryl ester was isolated by thin layer chromatography (TLC) on Silica gel 60 plates (F254, Merck Co.) using a petroleum ether-diethyl ether-acetic acid (90 : 10 : 1) solvent system. The distribution of radioactivity on TLC was analyzed with a radioscanner (radioanalytic imaging system, AMBISSystem Inc.) to determine the amount of cholesteryl [14C]oleate. OCT. 1992 Assay for Cholesteryl Ester Formation in J774 Macrophages J774 (J774.1) macrophages18) were routinely maintained in a growth medium (RPMI 1640 medium (GIBCO) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (GIBCO) and penicillin-streptomycin solution (final concentrations of benzylpenicillin at 50 units/ml and streptomycin at 50 /ig/ml)) in 25 cm2 tissue culture flaks (Corning Co.) at 37°C in a humidified incubator (95% air -5% CO2). Lipid dispersions having molar ratios of free cholesterol/phosphatidylcholine greater than 2 were prepared as reported previously19'20). Phosphatidylcholine (4 mg) dissolved in chloroform was dried under N2 in a 10-ml test tube and free cholesterol (16mg) in benzene was added. After mixing, the solvent was evaporated under N2 and the lipids were held in a vacuum desiccator for 2 hours. Then, 8 ml of sterilized 0.3m glucose was added and sonicated for 5 minutes.
Assay for cholesteryl ester formation in J774 macrophages was carried out according to the method described by McCloskey et al.20) with some modification. Two-day cultured J774 macrophages collected by centrifugation (800rpm, 5 minutes) were resuspended in the growth medium at a concentration of 1.0 x 106 cells/ml. Then 0.74 ml of the cell suspension was transferred into each well of 24-well microplates (Corning Co.). After 2-hour incubation the mediumwas changed to the same volume of FBS-free growth medium, and then the lipid dispersion (40jn\), [14C]oleic acid (0.25/xCi in lOjul of 50% aq ethanol) and various amounts of inhibitor (dissolved in 10\A of ethanol) were added to each well. The cells were incubated at 37°C in a humidified incubator (95% air-5% CO2). After 24 hours, 800/il of 0.1% SDS in PBS was added to each well. Lipids were extracted and separated on TLCas described above. Cell viability was also determined by the trypan blue dye exclusion method21} following 24-hour incubation of J774 cells in the FBS-free growth mediumwith the lipid dispersion and in the presence or absence of different concentrations of inhibitor.
Assay for Cholesteryl Ester Formation in Mouse Peritoneal Macrophages
Cholesteryl ester formation in cultured mouseperitoneal macrophageswas assayed by the methodof Nishikawa et al.12) Results Inhibitory Effect of Cyclodepsipeptides on ACATActivity in an Enzyme Assay The effect of beauvericin and enniatins on ACAT activity was tested in an assay using rat liver microsomes as a source of enzyme. As shown in Fig. 2r all of the compoundsinhibited the activity in a dose-dependent manner. Amongthem beauvericin showed the most potent inhibitory activity with an IC50 value of 3.0^m. Enniatins exhibited relatively weak inhibition (IC50 values: 22 to 1 10 /xm). The order of hydrophobicity of enniatins was estimated to be A, F, Al, E, Bl, D and B from the order eluted through an ODS-column by HPLC (Table 1) , and the data indicated a correlation between hydrophobicity and potency of activity against ACAT.However, beauvericin is not so hydrophobic because it was eluted between enniatin Bl and enniatin E. Under the same conditions, the IC50 values of the synthetic ACAT inhibitors CL 283,546 and CL 277,082 were 1.3 and 6.6/*m, respectively.
Effect of Cyclodepsipeptides on Cholesteryl Ester Formation in Macrophages
WhenJ774 macrophages were exposed to the mediumcontaining cholesterol-rich phospholipid dispersions, the formation of both cellular cholesteryl ester and triacylglycerol increased in a time-dependent fashion at least up to 24 hours (data not shown). In the presence of beauvericin or enniatins at various concentrations, the cholesteryl ester and triacylglycerol formations and cytotoxicity were measured. The results of beauvericin and enniatins A and D are shown in Fig. 3 , and similar results were obtained from the other enniatins. The cholesteryl ester formation was inhibited in a dose-dependent manner by these antibiotics, suggesting inhibition of ACATactivity in the living cell. The IC50 values for cholesteryl ester formation and cytotoxicity (CD50 values: drug concentration causing 50% cell damage) are summarized in Table 1 . Beauvericin showed the most potent inhibitory activity against cholesteryl ester formation in this cell assay with an IC50 value of 0.17/jm. The IC50 values of enniatins ranged between 0.28~1.1 fiM. The CD5O/IC5Oratios indicated that beauvericin shows much higher specificity for ACATinhibition than enniatins (Table 1) . Of all the compounds tested, CL 283,546 demonstrated the highest specificity (> 300), followed by beauvericin (65) and CL 277,082 (26). Interestingly, triacylglycerol formation was 1.5-to 4-fold enhanced at drug concentrations of cyclodepsipeptides where the formation of cholesteryl ester was inhibited. Such high enhancement was not observed for CL-283,546 (Fig. 3) . The specificity of beauvericin for ACAT inhibitory activity was further examined in another cell assay using primary cultures of mouse peritoneal macrophages. The effects on cholesteryl ester and triacylglycerol formations and cell viability were essentially similar (Fig. 4) to those in J774 cells, resulting in high specificity with a CD50/IC50 ratio of > 1 30. Enhancement of triacylglycerol formation was also observed to some extent (about 1.5-fold) in this cell assay.
Discussion
The cyclodepsipeptides beauvericin and enniatins behave as ionophore antibiotics in forming complexes with alkali metals. They exhibit various biological activities such as antimicrobial, insecticidal and cytotoxic activities. However, it seems still unclear whether these biological activities are actually derived from the ionophoric activity. In this paper, the cyclodepsipeptides were shown to exhibit a new biological activity of ACATinhibition. A good correlation was demonstrated between the ACATinhibition by enniatins in an enzyme assay (Fig. 2 ) and the hydrophobicity (Table 1) . More hydrophobic enniatins produced more potent ACAT inhibition.
However, the inhibitory activity of enniatins was not so strong. Since ACAT is a membrane-boundenzyme22), hydrophobic compoundscan associate with membranes and disturb the enzyme activity possibly in a non-specific manner. Onthe other hand, beauvericin of lower hydrophobicity exhibited the most potent ACATinhibitory activity (IC50: 3.0 /xm), suggesting possible specific ACAT inhibition by beauvericin. To our knowledge, beauvericin is one of the most potent ACATinhibitors of microbial origin in an enzyme assay. They are structurally different in that beauvericin contains L-phenylalanine instead of the branched alkyl amino acids of enniatins (Fig. 1) , indicating that the aromatic group in the structure may contribute to the ACATinhibition. The cell assay using J774 macrophages also demonstrated that beauvericin showed the most potent ACAT inhibition (IC50: 0.17 /im). As for J774 cytotoxicity, hydrophobic enniatins A, F, Al and E (CD50: 2.6 to 2.9jam) were more cytotoxic than other enniatins and beauvericin (CD50: approximately 10/im). This suggests that the hydrophobicity affects the cell viability, but not ACATactivity in the cell assay. As a result, beauvericin showedmuchhigher specificity than enniatins. In comparison with those of CL 283,546 and CL 277,082 under the same conditions, CL 283,546 is the most potent and specific ACAT inhibitor followed by beauvericin. Such high specificity of beauvericin for ACATinhibition was also observed in another cell assay using mouse peritoneal macrophages (Fig. 4) . Furthermore, triacylglycerol formation was enhanced for all the cyclodepsipeptides at the drug concentrations where cholesteryl ester formation was inhibited in both cell assays. This suggests that the substrate acyl-CoA accumulated by inhibiting ACAT is utilized predominantly for triacylglycerol synthesis.
A similar triacylglycerol accumulation by the ACATinhibitor 58-035 was reported in CaCo-2 cells by Kam et al.23 ) However, CL 283,546 had no effect on the triacylglycerol formation (Fig. 3) . Intracellular transport of acyl-CoA may also be affected by the compound. Taken together, beauvericin, regardless of its lower hydrophobicity and weaker antimicrobial activity, showed the most potent ACATinhibition in both enzyme and cell assays and the highest specificity in cell assays among the cyclodepsipeptides. The data indicate that the ACATinhibition by beauvericin may be independent of the ionophoric activity.
